Orchestra BioMed Holdings Statistics
Total Valuation
OBIO has a market cap or net worth of $287.38 million. The enterprise value is $213.97 million.
| Market Cap | 287.38M |
| Enterprise Value | 213.97M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OBIO has 35.79 million shares outstanding. The number of shares has increased by 29.43% in one year.
| Shares Outstanding | 35.79M |
| Shares Change (YoY) | +29.43% |
| Shares Change (QoQ) | +1.81% |
| Owned by Insiders (%) | 33.67% |
| Owned by Institutions (%) | 41.63% |
| Float | 19.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 129.68 |
| Forward PS | 81.68 |
| PB Ratio | 5.03 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 96.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.34, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.34 |
| Quick Ratio | 7.21 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -57.35 |
Financial Efficiency
Return on equity (ROE) is -70.20% and return on invested capital (ROIC) is -92.47%.
| Return on Equity (ROE) | -70.20% |
| Return on Assets (ROA) | -49.20% |
| Return on Capital (ROIC) | -92.47% |
| Revenue Per Employee | $39,571 |
| Profits Per Employee | -$922,196 |
| Employee Count | 56 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 1.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.22% in the last 52 weeks. The beta is 0.41, so OBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +8.22% |
| 50-Day Moving Average | 6.95 |
| 200-Day Moving Average | 6.56 |
| Relative Strength Index (RSI) | 54.76 |
| Average Volume (20 Days) | 248,289 |
Short Selling Information
The latest short interest is 821,045, so 2.29% of the outstanding shares have been sold short.
| Short Interest | 821,045 |
| Short Previous Month | 767,567 |
| Short % of Shares Out | 2.29% |
| Short % of Float | 4.31% |
| Short Ratio (days to cover) | 11.90 |
Income Statement
In the last 12 months, OBIO had revenue of $2.22 million and -$51.64 million in losses. Loss per share was -$1.48.
| Revenue | 2.22M |
| Gross Profit | 2.04M |
| Operating Income | -54.38M |
| Pretax Income | -51.64M |
| Net Income | -51.64M |
| EBITDA | -49.94M |
| EBIT | -50.76M |
| Loss Per Share | -$1.48 |
Balance Sheet
The company has $75.04 million in cash and $1.62 million in debt, giving a net cash position of $73.41 million or $2.05 per share.
| Cash & Cash Equivalents | 75.04M |
| Total Debt | 1.62M |
| Net Cash | 73.41M |
| Net Cash Per Share | $2.05 |
| Equity (Book Value) | 57.19M |
| Book Value Per Share | 1.60 |
| Working Capital | 66.01M |
Cash Flow
In the last 12 months, operating cash flow was -$44.86 million and capital expenditures -$51,000, giving a free cash flow of -$44.91 million.
| Operating Cash Flow | -44.86M |
| Capital Expenditures | -51,000 |
| Free Cash Flow | -44.91M |
| FCF Per Share | -$1.26 |
Margins
Gross margin is 92.06%, with operating and profit margins of -2,454.15% and -2,330.46%.
| Gross Margin | 92.06% |
| Operating Margin | -2,454.15% |
| Pretax Margin | -2,330.46% |
| Profit Margin | -2,330.46% |
| EBITDA Margin | -2,253.47% |
| EBIT Margin | -2,290.52% |
| FCF Margin | -2,026.67% |
Dividends & Yields
OBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.43% |
| Shareholder Yield | -29.43% |
| Earnings Yield | -17.97% |
| FCF Yield | -15.63% |
Analyst Forecast
The average price target for OBIO is $17.00, which is 111.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.00 |
| Price Target Difference | 111.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 63.03% |
| EPS Growth Forecast (5Y) | -18.87% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OBIO has an Altman Z-Score of 1.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.29 |
| Piotroski F-Score | 2 |